{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-022371","form_type":"8-K","ticker":"APGE","cik":"0001974640","company_name":"Apogee Therapeutics, Inc.","filed_at":"2025-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.692995+00:00","generated_at":"2026-05-25T00:11:25.512990+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Apogee Therapeutics enters manufacturing agreement with Samsung Biologics for APG777 drug substance","bullets":["Master Services Agreement with Samsung Biologics for manufacture and supply of APG777 drug substance for clinical development and commercial sale if approved.","Initial Project Specific Agreement for clinical batches, process characterization/validation, and process performance qualification lots at Samsung's Incheon facility.","Minimum purchase quantities under Initial PSA; commercial supply PSA from 2029-2034 with minimum commitments; exit fee high single digit millions if not entered.","MSA terminates February 2035; Initial PSA terminates December 2034; termination rights for material breach, insolvency, force majeure.","Upon termination, Samsung to assist with technology transfer; without-cause termination results in payment for remaining product commitment."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-022371","json":"https://secwatch.observer/filing/0001104659-25-022371.json","markdown":"https://secwatch.observer/filing/0001104659-25-022371.md","text":"https://secwatch.observer/filing/0001104659-25-022371.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1974640/000110465925022371/0001104659-25-022371-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1974640/000110465925022371/tm258743d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T00:11:25.512990+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}